{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:29:49Z","timestamp":1791268189665,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/jac\/dki252","type":"journal-article","created":{"date-parts":[[2005,7,8]],"date-time":"2005-07-08T20:14:01Z","timestamp":1120853641000},"page":"594-597","source":"Crossref","is-referenced-by-count":55,"title":["Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF"],"prefix":"10.1093","volume":"56","author":[{"given":"Edward","family":"Sionov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mendlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,7,8]]},"reference":[{"key":"key\n\t\t\t\t20171012170607_B1","doi-asserted-by":"crossref","unstructured":"Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis1996; 23: 608\u201315.","DOI":"10.1093\/clinids\/23.3.608"},{"key":"key\n\t\t\t\t20171012170607_B2","doi-asserted-by":"crossref","unstructured":"Kontoyiannis DP, Lewis RE. Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist Updat2003; 6: 257\u201369.","DOI":"10.1016\/j.drup.2003.08.003"},{"key":"key\n\t\t\t\t20171012170607_B3","doi-asserted-by":"crossref","unstructured":"Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis2002; 21: 161\u201372.","DOI":"10.1007\/s10096-002-0699-z"},{"key":"key\n\t\t\t\t20171012170607_B4","doi-asserted-by":"crossref","unstructured":"Shadkhan Y, Segal E, Bor A et al. The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures. J Antimicrob Chemother1997; 39: 655\u20138.","DOI":"10.1093\/jac\/39.5.655"},{"key":"key\n\t\t\t\t20171012170607_B5","doi-asserted-by":"crossref","unstructured":"Sionov E, Segal E. Treatment of murine systemic aspergillosis with polyene-intralipid admixtures. Med Mycol2004; 42: 73\u201380.","DOI":"10.1080\/13693780310001598871"},{"key":"key\n\t\t\t\t20171012170607_B6","doi-asserted-by":"crossref","unstructured":"Groll AH, Walsh TJ. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections. Expert Opin Invest Drugs2001; 10: 1545\u201358.","DOI":"10.1517\/13543784.10.8.1545"},{"key":"key\n\t\t\t\t20171012170607_B7","doi-asserted-by":"crossref","unstructured":"Roilides E, Walsh TJ, Pizzo P et al. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis1991; 163: 579\u201383.","DOI":"10.1093\/infdis\/163.3.579"},{"key":"key\n\t\t\t\t20171012170607_B8","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Uchida K, Klein TW et al. Immunomodulators and fungal infections: use of antifungal drugs in combination with G-CSF. In: Friedman H, ed. Microbial Infections. New York: Plenum Press, 1992; 231\u201341.","DOI":"10.1007\/978-1-4615-3434-1_24"},{"key":"key\n\t\t\t\t20171012170607_B9","doi-asserted-by":"crossref","unstructured":"Sionov E, Segal E. Polyene and cytokine treatment of experimental aspergillosis. FEMS Immunol Med Microbiol2003; 39: 221\u20137.","DOI":"10.1016\/S0928-8244(03)00230-X"},{"key":"key\n\t\t\t\t20171012170607_B10","doi-asserted-by":"crossref","unstructured":"Wallace TL, Paetznick V, Cossum PA et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob Agents Chemother1997; 41: 2238\u201343.","DOI":"10.1128\/AAC.41.10.2238"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/3\/594\/2030011\/dki252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T17:15:08Z","timestamp":1551806108000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/3\/594\/691013\/Experimental-systemic-murine-aspergillosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,8]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,7,8]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki252","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1026941.326499","asserted-by":"object"}]},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,7,8]]}}}